Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
The closing price of Galectin Therapeutics Inc (NASDAQ: GALT) was $3.45 for the day, down -11.08% from the previous closing price of $3.88. In other words, the price has decreased by -$11.08 from its previous closing price. On the day, 0.91 million shares were traded. GALT stock price reached its highest trading level at $3.9499 during the session, while it also had its lowest trading level at $3.34.
Ratios:
Our analysis of GALT’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 0.09 and its Current Ratio is at 0.09.
On August 13, 2020, H.C. Wainwright reiterated its Buy rating and also lowered its target price recommendation from $9 to $12.
On February 13, 2019, B. Riley FBR started tracking the stock assigning a Buy rating and target price of $11.B. Riley FBR initiated its Buy rating on February 13, 2019, with a $11 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Jan 06 ’26 when LEWIS JOEL sold 37,698 shares for $3.58 per share. The transaction valued at 134,853 led to the insider holds 832,592 shares of the business.
LEWIS JOEL sold 27,731 shares of GALT for $108,342 on Jan 05 ’26. The President and CEO now owns 870,290 shares after completing the transaction at $3.91 per share. On Jan 02 ’26, another insider, LEWIS JOEL, who serves as the President and CEO of the company, sold 18,571 shares for $4.20 each. As a result, the insider received 77,939 and left with 898,021 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, GALT now has a Market Capitalization of 222453264 and an Enterprise Value of 339173120.
Stock Price History:
The Beta on a monthly basis for GALT is 1.01, which has changed by 2.4336283 over the last 52 weeks, in comparison to a change of 0.16623151 over the same period for the S&P500. Over the past 52 weeks, GALT has reached a high of $7.13, while it has fallen to a 52-week low of $1.07. The 50-Day Moving Average of the stock is -35.27%, while the 200-Day Moving Average is calculated to be -0.42%.
Shares Statistics:
GALT traded an average of 503.08K shares per day over the past three months and 897620 shares per day over the past ten days. A total of 64.47M shares are outstanding, with a floating share count of 45.57M. Insiders hold about 29.33% of the company’s shares, while institutions hold 15.97% stake in the company. Shares short for GALT as of 1765756800 were 5950487 with a Short Ratio of 11.83, compared to 1763078400 on 6757137. Therefore, it implies a Short% of Shares Outstanding of 5950487 and a Short% of Float of 13.059999999999999.
Earnings Estimates
The firm’s stock currently is rated by 1.0 analysts. Analysts are recommending an EPS of between -$0.49 and -$0.49 for the fiscal current year, implying an average EPS of -$0.49. EPS for the following year is -$0.41, with 1.0 analysts recommending between -$0.41 and -$0.41.
